MEDALCHEMY SL
MEDALCHEMY SL is a Spanish GMP-certified pharmaceutical CDMO founded in 2002, offering custom synthesis, scale-up, pilot plant manufacturing (up to 25-30 kg/batch), and regulatory documentation services to pharmaceutical and biotechnology companies.
- Company typePrivate
- Founded2002
- HeadquartersSan Vicente del Raspeig, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MEDALCHEMY SL does
MEDALCHEMY SL is a Spanish pharmaceutical contract development and manufacturing organization (CDMO) founded in 2002 and headquartered in San Vicente del Raspeig, Alicante, Spain. The company provides integrated pharmaceutical R&D and manufacturing services to pharmaceutical and biotechnology companies, with capabilities spanning custom synthesis, process development, scale-up, pilot plant manufacturing (up to 25-30 kg per batch), quality control and analytical services, and cGMP-compliant API manufacturing. The company also offers CRO services for third-party research and development and prepares regulatory documentation including drug master files (ASMF) and Investigational Medicinal Product Dossiers (IMPD) for clinical trial and marketing authorization submissions.
The technical platform is built around specialized chemical processing equipment, including glass-lined and stainless steel jacketed reactors, high-vacuum short-path distillation units for kilo-scale heat-sensitive materials, and low-temperature reaction capability down to -90°C. The company operates under GMP, cGMP, ICH Q7, ICH-Q1A (R2), and ICH-Q1B certifications, allowing it to serve clients from early-stage custom synthesis (milligram scale) through clinical trial material production and small-volume commercial API supply. Its product portfolio includes fine chemicals, pharmaceutical impurities, chemical intermediates, novel molecules, small-volume APIs, and small-volume drug substances.
The business operates as a B2B enterprise services company with a 33-employee headcount, generating revenue through project-based CRO/CDMO engagements and one-time licensing/sale of APIs and chemical intermediates. Pricing is quote-based and project-specific with no publicly disclosed rates. The company engages clients directly via its website contact channel and industry networking, and operates as a privately held Spanish entity (Sociedad Limitada) affiliated with Curaleaf International, as evidenced by shared data protection officer contact and co-branded web presence. Revenue figures are not publicly disclosed.
MEDALCHEMY SL firmographics
Firmographics- Name
- MEDALCHEMY SL
- Legal name
- MEDALCHEMY SL
- Website
- https://medalchemy.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MEDALCHEMY SL is a Spanish GMP-certified pharmaceutical CDMO founded in 2002, offering custom synthesis, scale-up, pilot plant manufacturing (up to 25-30 kg/batch), and regulatory documentation services to pharmaceutical and biotechnology companies.
- Ownership category
- akta.pro rank
Where MEDALCHEMY SL is headquartered
LocationHeadquarters
- HQ city
- San Vicente del Raspeig
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
MEDALCHEMY SL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- CRO Services: Contract research organization services for third-party pharmaceutical research and development, including custom synthesis, process development, and analytical services.
- API and Therapeutic Molecule Manufacturing: Manufacturing and sale of active pharmaceutical ingredients, fine chemicals, pharmaceutical impurities, chemical intermediates, and new molecules for pharmaceutical and research applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
MEDALCHEMY SL product offering
Product offeringCore offering
MEDALCHEMY SL is a pharmaceutical R&D and contract manufacturing company that develops active pharmaceutical ingredients (APIs), fine chemicals, and new chemical entities within GMP-certified environments. It provides contract research organization (CRO) services spanning custom synthesis, process development, scale-up (gram to kilogram), pilot plant manufacturing up to 25-30 kg per batch, analytical method validation, stability studies, and regulatory documentation (ASMF, IMPD) for clinical trials and marketing authorisation.
Product overview
Medalchemy SL is a technology-driven pharmaceutical R&D company founded in 2002 offering a portfolio of six distinct product categories: Fine chemicals (high-purity compounds for pharmaceutical and research applications), Impurities of pharmaceuticals (reference materials for testing and validation), Chemical intermediates (for complex synthesis and manufacturing), New molecules (innovative molecules with therapeutic potential), Small volume APIs (GMP-compliant active pharmaceutical ingredients), and Small volume drugs. The company complements its product offerings with comprehensive service capabilities including Research and Development, Process development, Scale-up, Pilot plant manufacturing (up to 25-30 kg per batch), Quality Control and Analysis (validation, stability studies, physicochemical/microbiological testing), and Good Manufacturing Practice services (cGMP manufacturing, drug master files, IMPDs). The company also provides trusted CRO services for third-party research and development.
Differentiator
Problem solved
Functional benefit
Products and services
- Research and Development / Custom Synthesis Initial research and custom synthesis of building blocks, intermediates, APIs, and other molecules from milligrams to several grams for pharmaceutical clients.
- Process Development Synthetic route development based on existing literature or alternative new pathways for pharmaceutical manufacturing processes.
- Scale-up (Kilolab) Scale-up of synthetic processes from grams to several kilos using economically and ecologically viable processes in kilolab facilities.
- Pilot Plant Manufacturing Manufacturing up to 25-30 kg per batch following ICH Q7 guidelines, with process validation to enable use in clinical trials or as an API.
- Quality Control and Analysis Analytical method validation, stability studies following ICH-Q1A (R2) and ICH-Q1B guidelines, sample storage in climatic chambers, and physicochemical and microbiological testing.
- Good Manufacturing Practice (GMP) Services cGMP manufacturing at any scale for regulatory needs, including preparation of Active Substance Master Files (ASMF) for marketing authorisation and Investigational Medicinal Product Dossiers (IMPD) for clinical trials.
- CRO Services Contract research organization services for third-party pharmaceutical research and development covering custom synthesis, process development, scale-up, pilot plant manufacturing, and regulatory support.
- Fine Chemicals High-purity chemical compounds developed for pharmaceutical and research applications, produced through the company's synthesis capabilities.
- Pharmaceutical Impurities Reference impurities and analytical materials produced for pharmaceutical testing and validation.
- Chemical Intermediates Specialized chemical intermediates designed to support complex synthesis and manufacturing processes.
- New Molecules Research and development of innovative molecules with therapeutic potential and commercial value.
- Small Volume APIs GMP-compliant active pharmaceutical ingredients produced in small-scale batches for clinical and specialized use.
- Small Volume Drugs Small-scale pharmaceutical drug products manufactured for clinical and specialized applications.
Quantifiable outcome
- Pilot plant can manufacture up to 25-30 kg per batch
- +2 more outcomes
Companies that use MEDALCHEMY SL
Customer profileSegments2 records
Ideal customer profiles2 records
MEDALCHEMY SL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
MEDALCHEMY SL partnerships and signals
Strategic signalScale indicators3 records
Recent moves3 records
Expansion highlights3 records
MEDALCHEMY SL competitors and assessment
Company assessmentDirect peers
- PharmaZell: PharmaZell is a German-headquartered CDMO specializing in API manufacturing, process development, and GMP production for niche pharmaceutical applications. Closely comparable to Medalchemy as a mid-sized European API-focused CDMO.
- Carbogen Amcis: Carbogen Amcis is a Swiss CDMO (subsidiary of Dishman Carbogen Amcis) offering API development, custom synthesis, and GMP manufacturing with strength in complex chemistry and high-potency compounds. Comparable to Medalchemy's specialized synthesis and pilot-scale API capabilities.
- Hovione: Hovione is a Portugal-based CDMO specializing in API development, custom synthesis, and GMP manufacturing with pilot and commercial scale capabilities. Highly comparable to Medalchemy as a European small-molecule CDMO serving pharma and biotech clients across the development lifecycle.
- Aenova Group: Aenova is a German-headquartered pharmaceutical CDMO offering API manufacturing, formulation development, and finished dosage form production. Comparable to Medalchemy as a European CDMO serving pharma and biotech across development and manufacturing stages.
- Siegfried Holding: Siegfried is a Swiss CDMO focused on API manufacturing including custom synthesis, process development, and GMP production for the pharmaceutical industry. Direct comparable to Medalchemy's API development and GMP manufacturing business, with larger scale.
- Recipharm: Recipharm is a Swedish-headquartered CDMO offering API manufacturing, development services, and pharmaceutical contract manufacturing across multiple dosage forms. Comparable to Medalchemy as a European CDMO serving pharma and biotech with API development and GMP manufacturing capabilities.
Broad incumbents
- Catalent: Catalent is a large global CDMO offering development, manufacturing, and clinical supply services across multiple modalities and dosage forms. Competes with Medalchemy in early-phase API and drug product development, though at significantly larger scale and broader service scope.
- Eurofins Scientific: Eurofins is a global testing, contract research, and CDMO services provider with strong European footprint and analytical chemistry capabilities. Overlaps with Medalchemy's analytical method validation, stability studies, and contract research services.
- Lonza: Lonza is a global Swiss-headquartered CDMO offering API development, custom synthesis, and large-scale GMP manufacturing for small molecules and biologics. Broader incumbent competing with Medalchemy for API contracts, with much larger scale and broader service portfolio.
- WuXi AppTec / WuXi STA: WuXi STA is the global CDMO arm of WuXi AppTec, offering custom synthesis, process development, and GMP API manufacturing. A broad incumbent competing with Medalchemy across the small-molecule API development and manufacturing value chain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
MEDALCHEMY SL social profiles
Digital presenceMEDALCHEMY SL compliance and trust
Trust signalCompliance5 records
MEDALCHEMY SL financial estimates
Financial estimateRevenue estimate
Valuation estimate
MEDALCHEMY SL leadership team
Management profileNumber of profiles
Profiles1 record
MEDALCHEMY SL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MEDALCHEMY SL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MEDALCHEMY SL
What does MEDALCHEMY SL do?
MEDALCHEMY SL is a pharmaceutical R&D and contract manufacturing company that develops active pharmaceutical ingredients (APIs), fine chemicals, and new chemical entities within GMP-certified environments. It provides contract research organization (CRO) services spanning custom synthesis, process development, scale-up (gram to kilogram), pilot plant manufacturing up to 25-30 kg per batch, analytical method validation, stability studies, and regulatory documentation (ASMF, IMPD) for clinical trials and marketing authorisation.
Is MEDALCHEMY SL a public or private company?
MEDALCHEMY SL is a private company. It is classified as corporate owned and is currently operating.
When was MEDALCHEMY SL founded?
MEDALCHEMY SL was founded in 2002. It employs 11 to 50 people.
Where is MEDALCHEMY SL based?
MEDALCHEMY SL is headquartered in San Vicente del Raspeig, Spain, in the Europe region.
How does MEDALCHEMY SL make money?
Two revenue lines are on record. CRO Services are the primary driver. The others are API and Therapeutic Molecule Manufacturing.
Who are MEDALCHEMY SL's main competitors?
Direct peers on record are PharmaZell, Carbogen Amcis, Hovione, Aenova Group, Siegfried Holding and Recipharm. Broad incumbents are Catalent, Eurofins Scientific, Lonza and WuXi AppTec / WuXi STA.
Does MEDALCHEMY SL have an API?
No public API is recorded for MEDALCHEMY SL.